Surgical Sutures Market by Product (Suture Thread (Natural, Synthetic ), Automated Suturing Device), Type, Application, End User & Region - Global Forecast to 2030
The global surgical sutures market is projected to reach USD 6.65 billion by 2030 from USD 4.84 billion in 2025, at a CAGR of 6.5% during the forecast period."
Scope of the Report
Years Considered for the Study
2024-2030
Base Year
2024
Forecast Period
2025-2030
Units Considered
Value (USD billion)
Segments
Product, Type, Application, End User, and Region
Regions covered
North America, Europe, Asia Pacific, Latin America, Middle East, and Africa
The growth in the global surgical procedures landscape can be attributed primarily to the increasing prevalence of chronic conditions associated with an aging demographic, notably diabetes, cardiovascular diseases, and musculoskeletal disorders, all of which frequently necessitate surgical intervention. Furthermore, the rising incidence of trauma and accidents contributes to an uptick in suture demand. Innovations such as absorbable, antibacterial, and barbed sutures significantly improve surgical outcomes and mitigate infection risks, thereby catalyzing market growth. Additionally, the ascent of robotic and minimally invasive surgical techniques, which require advanced suturing methodologies, continues to propel the market forward, highlighting the need for precision in wound closure.
"By product, the suture threads segment had the largest market share in the surgical sutures market in 2024."
Suture thread is a critical component for wound closure across various surgical disciplines, thereby securing a substantial share of the surgical sutures market. It plays a vital role in traditional open surgeries and minimally invasive techniques, serving as the cornerstone of any suturing system. The thread's dominance can be attributed to its versatility, the diverse selection of available materials, and ongoing innovations to enhance its performance and efficacy. Advanced suture threads-such as absorbable, non-absorbable, antibacterial-coated, and barbed varieties-have significantly broadened their applicability in general, orthopedic, gynecological, and cardiovascular surgery. Surgeons prefer threads that exhibit high tensile strength, minimal tissue reactivity, and predictable absorption rates. In response, leading manufacturers continually refine these properties to meet the evolving demands of the surgical landscape.
"By type, the multifilament sutures segment held the largest share in the surgical sutures market in 2024."
The surgical suture market is predominantly characterized by multifilament sutures, owing to their superior handling properties, enhanced knot security, and adaptability across various surgical domains. Comprising multiple braided or twisted strands, multifilament sutures exhibit greater strength and pliability than monofilament options, making them particularly well-suited for precise tissue approximation procedures. Their ease of manipulation and excellent knot retention are crucial in minimizing surgical time, a significant advantage in high-demand operating environments. Furthermore, the soft and flexible nature of multifilament sutures minimizes tissue irritation, rendering them ideal for intricate surgical interventions, including gastrointestinal, cardiovascular, and gynecological operations.
"The US is expected to grow at the highest CAGR in the North American surgical sutures market during the study period."
The increasing number of surgical procedures can be primarily attributed to two significant factors: an aging population and a high prevalence of chronic health conditions such as diabetes, obesity, and cardiovascular diseases. These conditions often necessitate surgical intervention to manage complications and improve patients' quality of life. As the demographic landscape shifts with a growing elderly population, healthcare systems face heightened demand for surgical solutions. In addition to these demographic trends, the US boasts a sophisticated healthcare infrastructure that includes extensive hospital networks and improved access to surgical care. This accessibility has led to a rise in the number of surgeries performed, reflecting a broader shift towards proactive healthcare management. Moreover, the US is recognized as a hub for medical innovation, largely due to the presence of leading companies like Ethicon and Medtronic. These firms are at the forefront of developing advanced surgical sutures to enhance patient outcomes. Their offerings include innovative products such as absorbable sutures, which eliminate the need for removal; barbed sutures, which simplify the surgical process by allowing for secure tissue closure without the need for knots; and antibacterial-coated sutures, which help reduce the risk of postoperative infections. The continuous introduction of these cutting-edge suture technologies plays a crucial role in the evolving landscape of surgical procedures. It underscores the commitment to improving surgical techniques and patient care in the US.
A breakdown of the primary participants (supply-side) for the surgical sutures market referred to in this report is provided below:
By Company Type: Tier 1-35%, Tier 2-40%, and Tier 3-25%
By Designation: C-level-45%, Director Level-35%, and Others-20%
By Region: North America-27%, Europe-25%, Asia Pacific-30%, Latin America- 8%, Middle East & Africa-10% .
Prominent players in the surgical sutures market are Ethicon [Johnson & Johnson] (US), Medtronic (Ireland), B.Braun SE (Germany), Advanced Medical Solutions Group Plc (UK), Healthium MedTech Limited (India), Boston Scientific Corporation (US) Zimmer Biomet Holdings, Inc. (US), Stryker (US), Smith+Nephew (UK), Conmed Corporation (US), Internacional Farmaceutica S.A. de C.V. (Mexico), Corza Medical (US), DemeTECH Corporation (US), Unisur Lifecare Pvt. Ltd (India), Assut Europe (Italy), RESORBA Medical GmbH (Germany), KATSAN Katgut Sanayi ve Tic. A.S. (Turkey), Sutumed Corp. (US), Mellon Medical (Netherlands), Futura Surgicare Pvt. Ltd. (India), GMD Group (Turkey), Lotus Surgicals Pvt Ltd (India), BioSintex (Romania), Meril Life Sciences Pvt. Ltd. (India), and Aqmen Medtech (India).
Research Coverage:
The report analyzes the surgical sutures market and aims to estimate the market size and future growth potential based on various segments such as product, type, application, end user, and region. The report also includes a competitive analysis of the key players in this market, along with their company profiles, service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will help market leaders and new entrants by providing information on the closest approximations of the revenue numbers for the surgical sutures market. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
Analysis of key drivers (increasing number of surgical procedures, rising incidence of trauma-related cases, growing medical tourism industry, rising incidence of chronic lifestyle-related diseases, advancements in surgical sutures), restraints (increasing preference for minimally invasive surgeries, presence of alternative wound care management products), opportunities (growth opportunities in low- and middle-income countries) and challenges (market saturation and pricing pressure).
Market Penetration: It includes extensive information on products the major players in the global surgical sutures market offers. The report includes various product, type, application, end user, and region segments.
Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global surgical sutures market.
Market Development: Thorough knowledge and analysis of the profitable rising markets by product, type, application, end user, and region.
Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global surgical sutures market.
Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global surgical sutures market.
TABLE OF CONTENTS
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 MARKET SHARE ANALYSIS
2.5 ASSUMPTIONS & LIMITATIONS
2.5.1 STUDY ASSUMPTIONS
2.5.2 LIMITATIONS
2.6 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 SURGICAL SUTURES MARKET OVERVIEW
4.2 ASIA PACIFIC: SURGICAL SUTURES MARKET, BY PRODUCT & TYPE
4.3 GEOGRAPHIC GROWTH OPPORTUNITIES
4.4 REGIONAL MIX: SURGICAL SUTURES MARKET
4.5 SURGICAL SUTURES MARKET: DEVELOPED VS. EMERGING ECONOMIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing number of surgical procedures
5.2.1.2 Growing number of trauma cases
5.2.1.3 Growing medical tourism industry
5.2.1.4 Rising incidence of chronic lifestyle-related diseases
5.2.1.5 Advancements in surgical sutures
5.2.2 RESTRAINTS
5.2.2.1 Increasing preference for minimally invasive surgeries
5.2.2.2 Presence of alternative wound care management products
5.2.3 OPPORTUNITIES
5.2.3.1 Growth opportunities in LMICs
5.2.4 CHALLENGES
5.2.4.1 Market saturation and pricing pressure
5.3 REGULATORY LANDSCAPE
5.3.1 REGULATORY FRAMEWORK
5.3.1.1 North America
5.3.1.1.1 US
5.3.1.1.2 Canada
5.3.1.2 Europe
5.3.2 ASIA PACIFIC
5.3.2.1 Japan
5.3.2.2 China
5.3.2.3 India
5.3.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.4 TECHNOLOGY ANALYSIS
5.4.1 KEY TECHNOLOGIES
5.4.1.1 Sutures with integrated sensors for detecting infection
5.4.1.2 Drug-eluting sutures for local therapeutic delivery
5.4.1.3 Barbed sutures
5.4.2 COMPLEMENTARY TECHNOLOGIES
5.4.2.1 Surgical robots
5.4.2.2 Surgical staplers and clips
5.4.3 ADJACENT TECHNOLOGIES
5.4.3.1 Bioengineered suture materials
5.4.3.2 AI-driven surgical assistance
5.5 INDUSTRY TRENDS
5.6 VALUE CHAIN ANALYSIS
5.7 SUPPLY CHAIN ANALYSIS
5.8 TRADE ANALYSIS
5.8.1 IMPORT DATA FOR HS CODE 300610
5.8.2 EXPORT DATA FOR HS CODE 300610
5.9 PRICING ANALYSIS
5.9.1 AVERAGE SELLING PRICE, BY KEY PLAYER, 2024
5.9.2 AVERAGE SELLING PRICE, BY REGION, 2024
5.10 PORTER'S FIVE FORCES ANALYSIS
5.10.1 THREAT OF NEW ENTRANTS
5.10.2 THREAT OF SUBSTITUTES
5.10.3 BARGAINING POWER OF SUPPLIERS
5.10.4 BARGAINING POWER OF BUYERS
5.10.5 INTENSITY OF COMPETITIVE RIVALRY
5.11 ADJACENT MARKET ANALYSIS
5.12 PATENT ANALYSIS
5.13 ECOSYSTEM ANALYSIS
5.14 KEY CONFERENCES & EVENTS, 2025-2026
5.15 CASE STUDIES
5.15.1 CASE STUDY 1: UNIVERSITY RESEARCHERS DEVELOP REAL-TIME NON-INVASIVE WOUND MONITORING
5.15.2 CASE STUDY 2: ORTHOPEDIC INNOVATION AND PATIENT OUTCOMES
5.15.3 CASE STUDY 3: REDUCING SURGICAL SITE INFECTIONS WITH VICRYL PLUS